Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$9.08 USD
+0.21 (2.37%)
Updated Oct 8, 2024 04:00 PM ET
Pre-Market: $9.07 -0.01 (-0.11%) 9:08 AM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.08 USD
+0.21 (2.37%)
Updated Oct 8, 2024 04:00 PM ET
Pre-Market: $9.07 -0.01 (-0.11%) 9:08 AM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Headwinds Persist, Major Markets Down 3rd Straight Day: DAL, AAL, UAL, WBA
by Mark Vickery
It's the third-straight day in the red for the Dow, S&P 500 and Nasdaq, which fell 0.07%, 0.15% and 0.47%, respectively.
Walgreens Boots (WBA) Q4 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal fourth-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.
Walgreens Boots Alliance (WBA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 6.25% and 1.08%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
5 Important Earnings Chart to Watch This Week
by Tracey Ryniec
There are more than just banks reporting this first week of earnings season.
Evaluating Struggling Walgreens (WBA) Stock Ahead of Q4 Earnings
by Benjamin Rains
Walgreens Boots Alliance (WBA) hasn't gained any sustained momentum during the market comeback, with the stock down 37% in 2020, against the S&P 500's 8% jump...
Will Walgreens (WBA) Post Dull Retail Numbers in Q4 Earnings?
by Zacks Equity Research
Walgreens' (WBA) retail pharmacy international sales remain dull in Q4 on difficult market scenario in the U.K.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens' Pharmacy International Arm Faces Coronavirus Woes
by Zacks Equity Research
Walgreens (WBA) expects the adverse impact of COVID-19 to continue in the fiscal fourth quarter.
Rite Aid (RAD) Surpasses Earnings & Sales Estimates in Q2
by Zacks Equity Research
Rite Aid's (RAD) Q2 results gain from solid demand, rise in same-store prescription count, strength in Elixir brand and cost-cutting plans.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $37.17 in the latest trading session, marking a +1.12% move from the prior day.
Walgreens (WBA) Up 6.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rite Aid Continues Expansion of Coronavirus Testing Sites
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations by adding 161 more sites in order to curb the effects of coronavirus.
Company News for Jul 10, 2020
by Zacks Equity Research
Companies In The News Are: BBBY, WBA, HELE, WFC.
Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal third-quarter results reflect overall top line improvement despite COVID-19-led business disruptions.
Company News for Jul 9, 2020
by Zacks Equity Research
Companies In The News Are: KKR, TMHC, WORK, WBA.
Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -24.55% and 1.59%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?
Tech Stocks Continue to Surge Higher
by Jeremy Mullin
The Nasdaq continues to hit highs despite the rise in COVID-19 cases.
Buy Beaten-Down Walgreens (WBA) Stock Ahead of Earnings?
by Benjamin Rains
Walgreens reports its Q3 FY20 financial results before the opening bell on Thursday, July 9. The question is should investors consider buying shares of the struggling pharmacy chain?
JPMorgan, FedEx, Oracle, Walgreens and Paycheck are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, FedEx, Oracle, Walgreens and Paycheck are part of Zacks Earnings Preview
Pharmaceutical Wholesale to Aid Walgreens' (WBA) Q3 Earnings?
by Zacks Equity Research
Walgreen Boots' (WBA) international businesses in the third quarter is likely to have suffered a huge blow with international trade coming almost to a standstill.
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News for Jul 2, 2020
by Zacks Equity Research
The Nasdaq and the S&P 500 closed higher on Wednesday as investors focused on signs of economic recovery and better than expected economic data.
What Will Push Stocks Higher?
by Sheraz Mian
We have seen some good economic data in recent days, with the June factory sector ISM and payroll numbers showing impressive momentum. So what will push stocks higher next?
Walgreens' Retail Pharmacy Grows Amid Coronavirus Crisis
by Zacks Equity Research
Walgreens' (WBA) tie-ups with Alphabet's life sciences and healthcare segment, Verily on multiple projects related to chronic ailments buoy optimism.
Rite Aid Adds More Testing Sites in Fight Against Coronavirus
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations by adding 21 more sites in order to curb the effects of coronavirus.